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Real-time 3D transoesophageal echocardiography evaluation of
the mitral valve area in patients with mitral stenosis
J. Dreyfus , E. Brochet , L. Lepage , D. Attias , C. Cueff , D.
Detaint , B. Iung , A. Vahanian , D. Messika-Zeitoun
Service de cardiologie, hôpital Bichat, Paris, France
Objectives.— Planimetry measured by two-dimensional transtho-
racic echocardiography (TTE, MVA2D) is the reference method for
the evaluation of the severity of mitral stenosis (MS) but is signiﬁ-
cantly less reliable when performed by non-experienced operators.
Real-time three-dimensional transoesophageal echocardiography
(RT3DTEE, MVA3D) may overcome this limitation but its accuracy
has never been evaluated.
Materials and methods.— We prospectively enrolled 43 patients
(59± 15 years, 86% female) referred for MS evaluation who under-
went the same day a TTE and a RT3DTEE. MVA2D was assessed by
experienced operators, MVA3D was measured by one experienced
(Level III) and one non-experienced operator (Level I) blinded of any
clinical and TTE information. RT3DE images were digitally stored
and analysed ofﬂine on a workstation using dedicated software
(QLab, Philips) in a random order. MVA3D was measured at the best
cross-section of the mitral valve deﬁned as the most perpendicular
and smallest oriﬁce
Results.— MVA3D measured by the experienced operator
(1.07± 0.31 cm2 [range 0.45—1.85]) did not differ from and
correlated well with MVA2D (1.08± 0.32 cm2 [range 0.54—2.00],
P = 0.84, r = 0.71, P < 0.001), and mean difference was small
(−0.01± 0.24 cm2). Similarly, the MVA3D measured by the non-
experienced operator (1.03± 0.31 cm2 [range 0.45—1.69]) did not
differ from and correlated well with MVA2D (P = 0.27, r = 0.66,
P < 0.001; mean difference −0.05± 0.26 cm2). RT3DTEE intra-
and interobserver (between experienced and non-experienced
operators) variability were respectively 0.13± 0.10 cm2 and
0.19± 0.14 cm2.
Conclusion.— RT3DTEE provides accurate and reproducible MVA
measurements similar to 2D planimetry performed by experienced
operators. Thus, RT3DTEE should be considered as an alternative
tool for the evaluation of MS severity, especially in patients with
poor echocardiographic windows or for team less accustomed to
evaluate patients with MS.
doi:10.1016/j.acvd.2011.03.067
Determinants of symptoms in aortic stenosis — Inﬂuence of
longitudinal strain
D. Attias a, L. Macronb, J. Dreyfusa, J.-L. Moninb, E. Brocheta, L.
Lepagea, B. Iunga, A. Vahaniana, D. Messika-Zeitouna
a Cardiology Department, Bichat Hospital, AP—HP, Paris, France
b Cardiology, Henri Mondor Hospital, AP—HP, Créteil, FrancePatients with severe aortic stenosis (AS) and reduced ejection frac-
tion (EF) should be promptly operated on. Global longitudinal strain
(GLS) has been proposed as a subtle subclinical marker of left ven-
a
o
i291
ricular (LV) systolic dysfunction and a potential prognostic factor
n asymptomatic patients with severe AS and preserved EF. How-
ver, the relation between longitudinal strain, EF, AS severity and
ymptoms has not been fully evaluated.
ethods and results.— This prospective study included 171 patients
73± 12 years, 40% female) with at least mild AS (deﬁned by mean
ressure gradient > 10mmHg). All patients had a comprehensive
ransthoracic echocardiography (TTE). Global and basal longitudinal
train (BLS) was measured ofﬂine with a speckle tracking method.
mong the global population, mean aortic valve area 1 cm2; mean
ressure gradient 44mmHg and mean EF 62%.
our subgroups were identiﬁed: 55 asymptomatic patients with non-
evere AS and normal EF (group 1); 37 patients with asymptomatic
evere AS and normal EF (group 2); 60 patients with symptomatic
evere AS and normal EF (group 3) and 19 patients with severe AS
nd LV systolic dysfunction (group 4). GLS was signiﬁcantly lower in
atients with severe AS and reduced EF than in patients with AS and
reserved EF (−13.7± 5 versus −18.3± 3 respectively, P = 0.0006).
n univariate analysis, the best correlation was found between GLS
nd EF (r = 0.48, P < 0.0001). In multivariate analysis performed
fter adjustment for AVA and EF; GLS was not independently asso-
iated with symptomatic status (P = 0.15).
asal longitudinal train decreased gradually according to AS sever-
ty, symptomatic status and LV dysfunction: BLS was higher in
atients with asymptomatic AS than in patients with symptomatic
evere AS or patients with severe AS and LV dysfunction (−16.1± 4
ersus −12,5± 3 versus −9,7± 5, P < 0.0001). In univariate analy-
is, the best correlation was found between BLS and mean pressure
radient (r = 0.46, P < 0.0001).
n multivariate analysis including BLS, EF and AVA; the independent
eterminants of symptomatic status were AVA (P = 0.0003) and BLS
P = 0.0003).
onclusions.— In a large population with a wide range of AS severity,
F and symptoms, BLS but not GLS, was independently associated
ith symptoms in patients with AS, suggesting it may provide inter-
sting prognosis information. However, because of an important
verlap for the same values of BLS, a cut-off value of BLS asso-
iated to symptomatic status seemed difﬁcult to be applied to the
lobal population.
urther studies looking at the relation between the progressive
ecrease of BLS for each individual and the apparition of symptoms
ay help to conﬁrm BLS as a prognostic marker among patients with
symptomatic severe AS and preserved EF.
oi:10.1016/j.acvd.2011.03.068
eterminants of non-invasive coronary ﬂow reserve in severe
ortic stenosis
.-L. Germaina, P. Meimouna, F. Elmkiesa, T. Benali a, F. Levyb, J.
oulangera, H. Zemir a, J. Clerca, A. Luycx-Borea, C. Tribouilloyb
CH de Compiegne, Compiegne, France
CHU Amiens Sud, Amiens, France
ackground.— The coronary ﬂow reserve (CFR) is progressively
mpaired with aortic stenosis (AS) severity, but there is a broad
ange of CFR in patients (pts) with severe AS, and the factors respon-
ible for this variability are weakly characterized. Our objective was
o assess the determinants of non-invasive CFR in pts with severe
S (≤ 1cm2 or ≤ 0.6 cm2/m2) and preserved left ventricular ejection
raction (LVEF > 50%).
ethods.— Fifty consecutive pts (72± 10 years, 19 women, mean
VEF 67± 11%) with isolated severe AS (mean 0.77± 0.2 cm2,
.42± 0.12 cm2/m2), no coronary artery disease, underwent
rospectively transthoracic-Doppler echocardiography including
FR measurement in the distal part of the left anterior descending
rtery (LAD) with intravenous adenosine infusion (140g/kg/min
ver 2min). CFR was deﬁned as hyperemic peak LAD ﬂow veloc-
ty divided by baseline ﬂow velocity. Ten normal subjects matched
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Conclusion.— Benﬂuorex-related valvulopathy shares numerous92
or age and gender, served as a control group. Clinical, plasma
T-proBNP, and valvulo-arterial impedence (Z) were also assessed.
esults.— When compared to controls, pts with AS had higher
aseline LAD ﬂow velocity (37± 10 vs. 28± 9 cm/s, P < 0.05), sim-
lar hyperemic LAD ﬂow velocity (84 20 vs. 85± 21, P =NS), and
onsequently lower CFR (2.35± 0.68 vs. 3.2± 0.8, P < 0.01). In
ts with AS, there was a signiﬁcant inverse correlation between
FR and age (r =−0.33), E/Ea (early diastolic transmitral ﬂow
elocity/early diastolic mitral tissue Doppler annular velocity), LV
ass/m2, NT-proBNP (r =−0.45), pulmonary artery systolic pressure
PASP), baseline LV rate-pressure product (LVPP) [(mean gradi-
nt + systolic blood pressure)× heart rate)], heart rate, and left
trial volume/m2 (LAV) (all, P < 0.05), and a signiﬁcant positive cor-
elation between CFR and LVEF, and deceleration time of E (all,
< 0.05). The correlation between CFR and Z was of borderline sig-
iﬁcance. Furthermore, compared to asymptomatic AS pts (n = 10),
ymptomatic AS pts had a more severely impaired CFR (2.2± 0.6 vs.
.76± 0.8, P < 0.05), higher baseline and lower hyperemic LAD ﬂow
elocities (all, P < 0.05), and higher NT-proBNP values (P = 0.01).
n multivariate analysis, after adjusting for AS severity, NT-proBNP
as the main independent predictor of CFR (P < 0.01), and among
chographic variables, PASP and LVPP (all, P < 0.01). PASP was inde-
endently predicted by age, DTE and LAV (all, P≤ 0.01).
onclusion.— In patients with severe AS and preserved LVEF, there is
relatively wide range of CFR values. CFR is more severely impaired
n symptomatic AS pts and is mainly determined by increased LV wall
tress and workload, and diastolic dysfunction.
oi:10.1016/j.acvd.2011.03.069
chocardiographic predictors of mitral regurgitation following
ercutaneous balloon mitral valvulotomy
. Saaidi , K. Selmi , A. Mokaddem , M.-R. Boujnah
Hopital Mongi Slim, La Marsa, Tunisia
ntroduction.— Percutaneous balloon mitral valvulotomy (PBMV) in
heumatic mitral stenosis is effective. However, complications such
s severe mitral regurgitation (MR) may occur. Therefore, it is jus-
iﬁed to predict the occurrence of this complication.
bjectives.— This study was undertaken to evaluate the morphology
f the mitral valve and the subvalvular apparatus as assessed by
chocardiography and its role in predicting the occurrence of MR
fter PBMV with the Inoue balloon.
ethods.— Three hundred and thirty patients who underwent 356
BMV were evaluated retrospectively. MR occurred in 22 proce-
ures (6.1%). We have compared the 22 patients who developed
R to 128 patients without MR or with mild to moderate MR. The
orphology of the mitral apparatus on the baseline echograms
as assessed: valvular mobility, thickening and calciﬁcation, com-
issural morphology, subvalvular thickening and heterogeneity of
esions distribution. Both Wilkins and Padial scores were calculated.
esults.— Echocardiographic predictors of severe MR were grade 2
R (odds ratio = 6), Wilkins score (9,8± 2,9 vs 8,1± 2,5; P = 0,004)
ith a cut-off point of 10 (odds-ratio = 3), Padial score (12± 1,6
s 8,8± 1,5; P < 0,001) with a cut-off point of 10 (odds-ratio = 28),
eterogeneity of lesions distribution in the anterior mitral leaﬂet
c
c
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odds-ratio = 17), commissural calciﬁcation (odds-ratio = 14) and
ubvalvular thickening (odds-ratio = 7). However, valvular mobility,
hickening and calciﬁcation were unable to predict severe MR. The
echanism of severe MR was valvular tear in the most thin zones as
ssessed on echocardiography.
onclusion.— Commissural calciﬁcation rather than valve calciﬁca-
ion and the heterogeneity of lesions distribution rather than their
everity are strong predictors of severe MR following PBMV. The
adial score based on these criteria has supplanted the Wilkins score
n predicting this complication.
oi:10.1016/j.acvd.2011.03.070
alvular heart disease associated with benﬂuorex therapy:
esults from the French multicentre registry
. le Vena, C. Tribouilloyb, G. Habibc, J.-P. Gueffetd, S.
aréchauxe, J.-C. Eicher f, B. Blanchard-Lemoineg, J. Rousseauh,
. Hénonb, Y. Jobica, Y. Étiennea
Service de cardiologie CHU de Brest, Brest, France
Service de cardiologie, CHU Sud, Amiens, France
Service de cardiologie, CHU La Timone, Marseille, France
Service de cardiologie, CHU de Nantes, Nantes, France
Hôpital cardiologique, Lille, France
Service de cardiologie, CHU Le Bocage, Dijon, France
Service de cardiologie, hôpital Bichat, Paris, France
Centre cardiologique du Nord, Saint-Denis, France
im.— The aim of this study is to report clinical characteris-
ics, consequences, echocardiographic features, and pathological
ndings encountered in patients suffering from valvular disease
ssociated with benﬂuorex exposure in a multicentre French
egistry.
ethods.— Forty patients suffering from unexplained restrictive
alvular disease with a previous exposition to benﬂuorex, a fen-
uramine derivative, were identiﬁed from eight French university
ospitals.
esults.— Patients were mostly women (87.5%) with a mean age
f 57 + 9 years and high body mass index of 30 + 7 kg/m2; 37.5% of
hem presented with severe heart failure symptoms (NYHA class
II and IV). Benﬂuorex mean daily dose was 415 + 131mg with total
herapy duration of 72 + 53months. Resulting cumulative dose was
10 + 675 g. Common echocardiographic ﬁndings were leaﬂets and
ubvalvular apparatus thickening and retraction. Aortic and mitral
alve regurgitations resulting from leaﬂets loss of coaptation were
he most frequent ﬁndings (87.5 and 82.5%) and were severe in
9 patients (72.5%). Multiple valve involvements were present in
1 cases (77.5%). Pulmonary arterial hypertension was identiﬁed in
0 cases (50%). Histopathological examination demonstrated abun-
ant extracellular matrix encasing the leaﬂets without modiﬁcation
f valve architecture. Fifteen patients (37.5%) underwent valvular
urgery.haracteristics with other drug-induced valvular disease. Clinical
onsequences may be serious with severe heart failure symptoms
hat may lead to surgical treatment.
